{"nctId":"NCT00152763","briefTitle":"Psychological Support for Patients With an Implantable Cardioverter Defibrillator","startDateStruct":{"date":"2003-10"},"conditions":["Anxiety","Depression"],"count":193,"armGroups":[{"label":"Cognitive Behavior Therapy - males","type":"EXPERIMENTAL","interventionNames":["Behavioral: Cognitive Behaviour Therapy (CBT)"]},{"label":"Cognitive Behavior Therapy - females","type":"EXPERIMENTAL","interventionNames":["Behavioral: Cognitive Behaviour Therapy (CBT)"]},{"label":"Usual Cardiac Care - Males","type":"ACTIVE_COMPARATOR","interventionNames":["Other: Usual Cardiac Care (UCC)"]},{"label":"Usual Cardiac Care - females","type":"ACTIVE_COMPARATOR","interventionNames":["Other: Usual Cardiac Care (UCC)"]}],"interventions":[{"name":"Cognitive Behaviour Therapy (CBT)","otherNames":[]},{"name":"Usual Cardiac Care (UCC)","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patients from either Toronto General hospital or St. Michael's Hospital who have coronary heart disease,\n* Receiving their first ICD implant for secondary prevention of SCD or for primary prevention of SCD and their underlying heart disease was hypertrophic cardiomyopathy.\n\nExclusion Criteria:\n\n* Not able to read or understand English;\n* Evidence of psychosis, dementia or cognitive impairment as documented in the patients' hospital records;\n* Receiving an ICD for primary prevention of ICD.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Hospital Anxiety and Depression Scale - Depression Scale at Baseline","description":"Psychometric scale measuring symptoms of depression, score range is 0 to 24. Scores \\>= 8 represent clinically elevated scores. Higher scores represent greater depressive symptoms.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.70","spread":"3.41"},{"groupId":"OG001","value":"7.47","spread":"5.02"},{"groupId":"OG002","value":"5.35","spread":"3.82"},{"groupId":"OG003","value":"4.12","spread":"4.01"}]}]}]},{"type":"SECONDARY","title":"SF-36 Mental Component Summary Scale at Baseline","description":"Quality of life measure - mental health summary, scores range from 0 to 100 with higher scores representing better mental health.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"45.90","spread":"13.40"},{"groupId":"OG001","value":"37.44","spread":"13.69"},{"groupId":"OG002","value":"42.33","spread":"12.43"},{"groupId":"OG003","value":"49.84","spread":"10.56"}]}]}]},{"type":"PRIMARY","title":"Hospital Anxiety and Depression Scale - Depression Scale at 6-months Follow-up","description":"Psychometric scale measuring symptoms of depression, score range is 0 to 24. Scores \\>= 8 represent clinically elevated scores. Higher scores represent greater depressive symptoms.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.21","spread":"3.31"},{"groupId":"OG001","value":"4.86","spread":"3.25"},{"groupId":"OG002","value":"5.50","spread":"4.22"},{"groupId":"OG003","value":"3.82","spread":"3.39"}]}]}]},{"type":"SECONDARY","title":"SF-36 Mental Component Summary Scale at 6-months Follow-up","description":"Quality of life measure - mental health summary, scores range from 0 to 100 with higher scores representing better mental health.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"48.73","spread":"10.34"},{"groupId":"OG001","value":"43.82","spread":"11.64"},{"groupId":"OG002","value":"45.67","spread":"10.84"},{"groupId":"OG003","value":"51.32","spread":"10.99"}]}]}]},{"type":"PRIMARY","title":"Hospital Anxiety and Depression Scale - Depression Scale at 12-months Follow-up","description":"Psychometric scale measuring symptoms of depression, score range is 0 to 24. Scores \\>= 8 represent clinically elevated scores. Higher scores represent greater depressive symptoms.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.52","spread":"3.29"},{"groupId":"OG001","value":"4.67","spread":"4.19"},{"groupId":"OG002","value":"5.87","spread":"3.12"},{"groupId":"OG003","value":"4.15","spread":"3.36"}]}]}]},{"type":"PRIMARY","title":"Hospital Anxiety and Depression Scale - Anxiety Scale at Baseline","description":"Psychometric scale measuring symptoms of anxiety,score range is 0 to 24. Scores \\>= 8 represent clinically elevated scores. Higher scores represent greater anxiety symptoms.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.53","spread":"4.26"},{"groupId":"OG001","value":"9.32","spread":"5.50"},{"groupId":"OG002","value":"7.70","spread":"3.85"},{"groupId":"OG003","value":"4.80","spread":"3.93"}]}]}]},{"type":"PRIMARY","title":"Hospital Anxiety and Depression Scale - Anxiety Scale at 6-months Follow-up","description":"Psychometric scale measuring symptoms of anxiety,score range is 0 to 24. Scores \\>= 8 represent clinically elevated scores. Higher scores represent greater anxiety symptoms.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.06","spread":"3.84"},{"groupId":"OG001","value":"7.28","spread":"4.01"},{"groupId":"OG002","value":"6.83","spread":"4.67"},{"groupId":"OG003","value":"4.69","spread":"3.92"}]}]}]},{"type":"PRIMARY","title":"Hospital Anxiety and Depression Scale - Anxiety Scale at 12-months Follow-up","description":"Psychometric scale measuring symptoms of anxiety,score range is 0 to 24. Scores \\>= 8 represent clinically elevated scores. Higher scores represent greater anxiety symptoms.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.06","spread":"3.97"},{"groupId":"OG001","value":"8.00","spread":"3.70"},{"groupId":"OG002","value":"7.25","spread":"3.57"},{"groupId":"OG003","value":"4.43","spread":"3.77"}]}]}]},{"type":"PRIMARY","title":"Impact of Events Scale-Revised - Total Score at Baseline","description":"Psychometric measure of post traumatic stress disorder symptoms, scores range from 0 to 4. A score threshold of 1.4 has been found to diagnostic of post traumatic stress disorder in war veterans. Higher scores represent greater total post traumatic stress disorder symptoms.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.81","spread":"0.66"},{"groupId":"OG001","value":"1.56","spread":"0.99"},{"groupId":"OG002","value":"1.20","spread":"0.85"},{"groupId":"OG003","value":"0.63","spread":"0.51"}]}]}]},{"type":"SECONDARY","title":"SF-36 Mental Component Summary Scale at 12-months Follow-up","description":"Quality of life measure - mental health summary, scores range from 0 to 100 with higher scores representing better mental health.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"49.92","spread":"10.50"},{"groupId":"OG001","value":"46.26","spread":"14.00"},{"groupId":"OG002","value":"41.58","spread":"9.02"},{"groupId":"OG003","value":"51.61","spread":"46.26"}]}]}]},{"type":"PRIMARY","title":"Impact of Events Scale-Revised - Total Score at 6-months Follow-up","description":"Psychometric measure of post traumatic stress disorder symptoms, scores range from 0 to 4. A score threshold of 1.4 has been found to diagnostic of post traumatic stress disorder in war veterans. Higher scores represent greater total post traumatic stress disorder symptoms.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.70","spread":"0.52"},{"groupId":"OG001","value":"0.76","spread":"0.83"},{"groupId":"OG002","value":"0.68","spread":"0.64"},{"groupId":"OG003","value":"0.54","spread":"0.62"}]}]}]},{"type":"PRIMARY","title":"Impact of Events Scale-Revised - Total Score at 12-months Follow-up","description":"Psychometric measure of post traumatic stress disorder symptoms, scores range from 0 to 4. A score threshold of 1.4 has been found to diagnostic of post traumatic stress disorder in war veterans. Higher scores represent greater total post traumatic stress disorder symptoms.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.70","spread":"0.64"},{"groupId":"OG001","value":"0.69","spread":"0.53"},{"groupId":"OG002","value":"0.82","spread":"0.69"},{"groupId":"OG003","value":"0.46","spread":"0.47"}]}]}]},{"type":"PRIMARY","title":"Impact of Events Scale-Revised - Intrusiveness Scale at Baseline","description":"Psychometric measure of post traumatic stress disorder intrusiveness symptoms, scores range from 0 to 4. Higher scores represent greater post traumatic stress disorder intrusiveness symptoms.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.80","spread":"0.71"},{"groupId":"OG001","value":"1.53","spread":"0.98"},{"groupId":"OG002","value":"1.25","spread":"0.95"},{"groupId":"OG003","value":"0.61","spread":"0.64"}]}]}]},{"type":"PRIMARY","title":"Impact of Events Scale-Revised - Intrusiveness Scale at 6-months Follow-up","description":"Psychometric measure of post traumatic stress disorder intrusiveness symptoms, scores range from 0 to 4. Higher scores represent greater post traumatic stress disorder intrusiveness symptoms.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.61","spread":"0.52"},{"groupId":"OG001","value":"0.82","spread":"0.96"},{"groupId":"OG002","value":"0.73","spread":"0.73"},{"groupId":"OG003","value":"0.56","spread":"0.73"}]}]}]},{"type":"PRIMARY","title":"Impact of Events Scale-Revised - Intrusiveness Scale at 12-months Follow-up","description":"Psychometric measure of post traumatic stress disorder intrusiveness symptoms, scores range from 0 to 4. Higher scores represent greater post traumatic stress disorder intrusiveness symptoms.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.62","spread":"0.62"},{"groupId":"OG001","value":"0.64","spread":"0.60"},{"groupId":"OG002","value":"0.80","spread":"0.70"},{"groupId":"OG003","value":"0.42","spread":"0.47"}]}]}]},{"type":"PRIMARY","title":"Impact of Events Scale-Revised - Avoidance Scale at Baseline","description":"Psychometric assessment of post traumatic stress disorder avoidance symptoms, scores range from 0 to 4. Higher scores represent greater post traumatic stress disorder avoidance symptoms.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.84","spread":"0.62"},{"groupId":"OG001","value":"1.68","spread":"1.10"},{"groupId":"OG002","value":"1.25","spread":"0.82"},{"groupId":"OG003","value":"0.64","spread":"0.58"}]}]}]},{"type":"PRIMARY","title":"Impact of Events Scale-Revised - Avoidance Scale at 6-months Follow-up","description":"Psychometric assessment of post traumatic stress disorder avoidance symptoms, scores range from 0 to 4. Higher scores represent greater post traumatic stress disorder avoidance symptoms.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.86","spread":"0.64"},{"groupId":"OG001","value":"0.77","spread":"0.87"},{"groupId":"OG002","value":"0.74","spread":"0.71"},{"groupId":"OG003","value":"0.55","spread":"0.64"}]}]}]},{"type":"PRIMARY","title":"Impact of Events Scale-Revised - Avoidance Scale at 12-months Follow-up","description":"Psychometric assessment of post traumatic stress disorder avoidance symptoms, scores range from 0 to 4. Higher scores represent greater post traumatic stress disorder avoidance symptoms.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.82","spread":"0.74"},{"groupId":"OG001","value":"0.84","spread":"0.65"},{"groupId":"OG002","value":"0.98","spread":"0.86"},{"groupId":"OG003","value":"0.57","spread":"0.66"}]}]}]},{"type":"PRIMARY","title":"Impact of Event Scale-Revised Hyperarousal Scale at Baseline","description":"Psychometric measure of post traumatic stress disorder hyper-arousal symptoms, scores range from 0 to 4. Higher scores represent greater post traumatic stress disorder hyperarousal symptoms.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.78","spread":"0.86"},{"groupId":"OG001","value":"1.40","spread":"1.11"},{"groupId":"OG002","value":"1.07","spread":"0.98"},{"groupId":"OG003","value":"0.64","spread":"0.67"}]}]}]},{"type":"PRIMARY","title":"Impact of Event Scale-Revised Hyperarousal Scale at 6-months Follow-up","description":"Psychometric measure of post traumatic stress disorder hyper-arousal symptoms, scores range from 0 to 4. Higher scores represent greater post traumatic stress disorder hyperarousal symptoms.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.61","spread":"0.70"},{"groupId":"OG001","value":"0.64","spread":"0.87"},{"groupId":"OG002","value":"0.56","spread":"0.61"},{"groupId":"OG003","value":"0.52","spread":"0.70"}]}]}]},{"type":"PRIMARY","title":"Impact of Event Scale-Revised Hyperarousal Scale at 12-months Follow-up","description":"Psychometric measure of post traumatic stress disorder hyper-arousal symptoms, scores range from 0 to 4. Higher scores represent greater post traumatic stress disorder hyperarousal symptoms.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.64","spread":"0.73"},{"groupId":"OG001","value":"0.57","spread":"0.54"},{"groupId":"OG002","value":"0.67","spread":"0.70"},{"groupId":"OG003","value":"0.39","spread":"0.43"}]}]}]},{"type":"PRIMARY","title":"Crown-Crisp Experiential Index - Phobic Anxiety Scale at Baseline","description":"Psychometric measure of phobic anxiety, scores range from 1 to 3. Higher scores represent greater phobic anxiety symptoms.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.98","spread":"0.39"},{"groupId":"OG001","value":"1.17","spread":"0.28"},{"groupId":"OG002","value":"1.23","spread":"0.41"},{"groupId":"OG003","value":"0.83","spread":"0.33"}]}]}]},{"type":"PRIMARY","title":"Crown-Crisp Experiential Index - Phobic Anxiety Scale at 6-months Follow-up","description":"Psychometric measure of phobic anxiety, scores range from 1 to 3. Higher scores represent greater phobic anxiety symptoms.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.92","spread":"0.40"},{"groupId":"OG001","value":"1.04","spread":"0.38"},{"groupId":"OG002","value":"1.07","spread":"0.36"},{"groupId":"OG003","value":"0.84","spread":"0.35"}]}]}]},{"type":"PRIMARY","title":"Crown-Crisp Experiential Index - Phobic Anxiety Scale at 12-months Follow-up","description":"Psychometric measure of phobic anxiety, scores range from 1 to 3. Higher scores represent greater phobic anxiety symptoms.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.98","spread":"0.40"},{"groupId":"OG001","value":"1.13","spread":"0.35"},{"groupId":"OG002","value":"1.07","spread":"0.40"},{"groupId":"OG003","value":"0.93","spread":"0.35"}]}]}]},{"type":"SECONDARY","title":"SF-36 Physical Component Summary Score at Baseline","description":"Quality of life measure of physical health, scores range from 0 to 100 with higher scores representing better physical health.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"39.19","spread":"10.46"},{"groupId":"OG001","value":"36.13","spread":"7.06"},{"groupId":"OG002","value":"37.60","spread":"11.81"},{"groupId":"OG003","value":"38.85","spread":"10.15"}]}]}]},{"type":"SECONDARY","title":"SF-36 Physical Component Summary Score at 6-months Follow-up","description":"Quality of life measure of physical health, scores range from 0 to 100 with higher scores representing better physical health.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"42.54","spread":"10.58"},{"groupId":"OG001","value":"41.46","spread":"12.43"},{"groupId":"OG002","value":"41.22","spread":"12.85"},{"groupId":"OG003","value":"42.69","spread":"10.06"}]}]}]},{"type":"SECONDARY","title":"SF-36 Physical Component Summary Score at 12-months Follow-up","description":"Quality of life measure of physical health, scores range from 0 to 100 with higher scores representing better physical health.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"42.65","spread":"10.33"},{"groupId":"OG001","value":"42.70","spread":"10.44"},{"groupId":"OG002","value":"42.82","spread":"14.53"},{"groupId":"OG003","value":"41.54","spread":"11.23"}]}]}]},{"type":"SECONDARY","title":"Percentage of Participants Who Received ICD Therapies","description":"Percentage of participants who received ICD shocks or anti-tachycardia therapies, data extracted from participants ICD devices over follow-up.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"30.5","spread":null},{"groupId":"OG001","value":"31.9","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":4,"n":77},"commonTop":[]}}}